---
title: "Kinase/Enzyme Assays"
canonical: "https://www.pharmalegacy.com/services/in-vitro-platform/kinase-enzyme-assays/"
lastmod: "2026-05-26T01:32:16+00:00"
generator: "llm-mirrors/1.0.19"
---

Comprehensive kinome screening is paramount for identifying selective and potent kinase inhibitors. Precise determination and subsequent optimization of compound selectivity through robust, high-throughput, kinome-wide screening is a cornerstone of novel kinase inhibitor discovery. This approach mitigates unwanted off-target effects associated with both kinases and non-kinase interactions, ultimately enhancing therapeutic efficacy and reducing adverse effects.
With over 400 kinases and enzymes available, PharmaLegacy provides you with a comprehensive stage for identifying and optimizing potent, selective inhibitors. We offer compound screening and SAR analysis for nuanced insights, kinase panel customization to tailor your approach, and the expertise to validate and develop assays for even the most novel targets. Our high-throughput 384-well format accelerates the pace of discovery, ensuring swift identification of promising leads.